JP Stock MarketDetailed Quotes

4547 Kissei Pharmaceutical

Watchlist
  • 3630
  • 00.00%
20min DelayMarket to Open Feb 17 15:30 JST
173.92BMarket Cap14.72P/E (Static)

Kissei Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
11.12%23.2B
9.58%21.16B
11.98%75.58B
11.74%17.72B
11.24%20.88B
6.55%17.67B
18.59%19.31B
3.23%67.49B
3.67%15.86B
6.07%18.77B
Cost of revenue
8.16%11.48B
5.68%10.28B
8.88%38.24B
0.85%8.94B
10.95%10.62B
4.70%8.95B
19.61%9.73B
2.86%35.12B
8.60%8.87B
5.71%9.57B
Gross profit
14.18%11.72B
13.54%10.88B
15.34%37.34B
25.57%8.78B
11.56%10.27B
8.50%8.72B
17.58%9.58B
3.64%32.37B
-1.98%6.99B
6.43%9.2B
Operating expense
14.14%9.26B
9.74%8.72B
-0.53%33.32B
3.63%8.92B
0.42%8.12B
-5.19%8.34B
-0.87%7.95B
2.64%33.5B
4.53%8.61B
-12.24%8.08B
Operating profit
14.33%2.46B
32.07%2.16B
455.80%4.02B
90.88%-148M
92.05%2.15B
150.46%382M
1,147.33%1.63B
19.47%-1.13B
-46.39%-1.62B
298.40%1.12B
Net non-operating interest income (expenses)
-53.33%7M
-80.00%2M
0.00%3M
-1,250.00%-23M
1,400.00%15M
1M
10M
-84.21%3M
100.00%2M
-80.00%1M
Non-operating interest income
-31.58%13M
-57.14%6M
-8.70%21M
-357.14%-18M
216.67%19M
20.00%6M
180.00%14M
-45.24%23M
0.00%7M
-45.45%6M
Non-operating interest expense
50.00%6M
0.00%4M
-10.00%18M
0.00%5M
-20.00%4M
0.00%5M
-20.00%4M
-13.04%20M
-16.67%5M
-16.67%5M
Net investment income
13.81%552M
6.44%645M
-23.71%1.19B
-89.75%33M
-5.27%485M
-51.72%70M
3.41%606M
5.46%1.57B
133.33%322M
-7.08%512M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
334.41%4.18B
37.78%2.87B
-30.56%9.12B
-44.13%3.37B
-67.02%962M
-5.22%2.7B
56.62%2.08B
-18.74%13.13B
-30.72%6.03B
119.32%2.92B
Income from associates and other participating interests
Special income (charges)
-18,466.67%-2.79B
-165M
66.67%80M
52.31%99M
-15M
76.47%-4M
0
237.14%48M
641.67%65M
0
Less:Other special charges
20.00%18M
--37M
-26.98%-80M
-52.31%-99M
--15M
----
----
-280.00%-63M
-641.67%-65M
--0
Less:Write off
--2.77B
--128M
--0
--0
--0
----
----
--15M
--0
--0
Other non-operating income (expenses)
150.00%5M
-17.65%14M
-39.66%35M
115.04%17M
-92.00%2M
-101.96%-1M
-82.11%17M
-79.36%58M
-268.66%-113M
-78.81%25M
Income before tax
22.71%4.42B
26.95%5.52B
5.62%14.45B
-28.59%3.35B
-21.30%3.6B
38.47%3.15B
103.13%4.35B
-17.13%13.68B
-39.83%4.69B
217.50%4.57B
Income tax
-9.97%813M
38.15%1.42B
3.71%3.16B
-36.13%511M
-24.56%903M
27.66%720M
111.34%1.03B
-12.35%3.05B
-51.95%800M
375.00%1.2B
Net income
33.65%3.6B
23.53%4.11B
6.16%11.29B
-27.07%2.84B
-20.17%2.7B
42.17%2.43B
100.66%3.32B
-18.40%10.63B
-36.53%3.89B
184.18%3.38B
Net income continuous operations
33.65%3.6B
23.50%4.11B
6.17%11.29B
-27.04%2.84B
-20.15%2.7B
42.03%2.43B
100.72%3.32B
-18.40%10.63B
-36.53%3.89B
184.09%3.38B
Noncontrolling interests
-67.57%12M
-101.75%-1M
21.90%128M
-53.57%13M
5.71%37M
-4.55%21M
185.00%57M
-4.55%105M
7.69%28M
0.00%35M
Net income attributable to the company
35.05%3.59B
25.76%4.11B
6.00%11.16B
-26.88%2.82B
-20.41%2.66B
42.70%2.41B
99.69%3.27B
-18.52%10.53B
-36.73%3.86B
189.77%3.34B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
35.05%3.59B
25.76%4.11B
6.00%11.16B
-26.88%2.82B
-20.41%2.66B
42.70%2.41B
99.69%3.27B
-18.52%10.53B
-36.73%3.86B
189.77%3.34B
Gross dividend payment
Basic earnings per share
39.59%82.65
30.92%92.89
8.02%246.61
-23.87%63.74
-18.27%59.21
43.78%52.71
100.03%70.95
-18.52%228.31
-36.73%83.73
189.80%72.45
Diluted earnings per share
39.59%82.65
30.92%92.89
8.02%246.61
-23.87%63.74
-18.27%59.21
43.71%52.6845
100.03%70.95
-18.52%228.31
-36.72%83.7244
189.79%72.4475
Dividend per share
0
0
2.50%82
2.50%41
0
2.50%41
0
42.86%80
42.86%40
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue 11.12%23.2B9.58%21.16B11.98%75.58B11.74%17.72B11.24%20.88B6.55%17.67B18.59%19.31B3.23%67.49B3.67%15.86B6.07%18.77B
Cost of revenue 8.16%11.48B5.68%10.28B8.88%38.24B0.85%8.94B10.95%10.62B4.70%8.95B19.61%9.73B2.86%35.12B8.60%8.87B5.71%9.57B
Gross profit 14.18%11.72B13.54%10.88B15.34%37.34B25.57%8.78B11.56%10.27B8.50%8.72B17.58%9.58B3.64%32.37B-1.98%6.99B6.43%9.2B
Operating expense 14.14%9.26B9.74%8.72B-0.53%33.32B3.63%8.92B0.42%8.12B-5.19%8.34B-0.87%7.95B2.64%33.5B4.53%8.61B-12.24%8.08B
Operating profit 14.33%2.46B32.07%2.16B455.80%4.02B90.88%-148M92.05%2.15B150.46%382M1,147.33%1.63B19.47%-1.13B-46.39%-1.62B298.40%1.12B
Net non-operating interest income (expenses) -53.33%7M-80.00%2M0.00%3M-1,250.00%-23M1,400.00%15M1M10M-84.21%3M100.00%2M-80.00%1M
Non-operating interest income -31.58%13M-57.14%6M-8.70%21M-357.14%-18M216.67%19M20.00%6M180.00%14M-45.24%23M0.00%7M-45.45%6M
Non-operating interest expense 50.00%6M0.00%4M-10.00%18M0.00%5M-20.00%4M0.00%5M-20.00%4M-13.04%20M-16.67%5M-16.67%5M
Net investment income 13.81%552M6.44%645M-23.71%1.19B-89.75%33M-5.27%485M-51.72%70M3.41%606M5.46%1.57B133.33%322M-7.08%512M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 334.41%4.18B37.78%2.87B-30.56%9.12B-44.13%3.37B-67.02%962M-5.22%2.7B56.62%2.08B-18.74%13.13B-30.72%6.03B119.32%2.92B
Income from associates and other participating interests
Special income (charges) -18,466.67%-2.79B-165M66.67%80M52.31%99M-15M76.47%-4M0237.14%48M641.67%65M0
Less:Other special charges 20.00%18M--37M-26.98%-80M-52.31%-99M--15M---------280.00%-63M-641.67%-65M--0
Less:Write off --2.77B--128M--0--0--0----------15M--0--0
Other non-operating income (expenses) 150.00%5M-17.65%14M-39.66%35M115.04%17M-92.00%2M-101.96%-1M-82.11%17M-79.36%58M-268.66%-113M-78.81%25M
Income before tax 22.71%4.42B26.95%5.52B5.62%14.45B-28.59%3.35B-21.30%3.6B38.47%3.15B103.13%4.35B-17.13%13.68B-39.83%4.69B217.50%4.57B
Income tax -9.97%813M38.15%1.42B3.71%3.16B-36.13%511M-24.56%903M27.66%720M111.34%1.03B-12.35%3.05B-51.95%800M375.00%1.2B
Net income 33.65%3.6B23.53%4.11B6.16%11.29B-27.07%2.84B-20.17%2.7B42.17%2.43B100.66%3.32B-18.40%10.63B-36.53%3.89B184.18%3.38B
Net income continuous operations 33.65%3.6B23.50%4.11B6.17%11.29B-27.04%2.84B-20.15%2.7B42.03%2.43B100.72%3.32B-18.40%10.63B-36.53%3.89B184.09%3.38B
Noncontrolling interests -67.57%12M-101.75%-1M21.90%128M-53.57%13M5.71%37M-4.55%21M185.00%57M-4.55%105M7.69%28M0.00%35M
Net income attributable to the company 35.05%3.59B25.76%4.11B6.00%11.16B-26.88%2.82B-20.41%2.66B42.70%2.41B99.69%3.27B-18.52%10.53B-36.73%3.86B189.77%3.34B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 35.05%3.59B25.76%4.11B6.00%11.16B-26.88%2.82B-20.41%2.66B42.70%2.41B99.69%3.27B-18.52%10.53B-36.73%3.86B189.77%3.34B
Gross dividend payment
Basic earnings per share 39.59%82.6530.92%92.898.02%246.61-23.87%63.74-18.27%59.2143.78%52.71100.03%70.95-18.52%228.31-36.73%83.73189.80%72.45
Diluted earnings per share 39.59%82.6530.92%92.898.02%246.61-23.87%63.74-18.27%59.2143.71%52.6845100.03%70.95-18.52%228.31-36.72%83.7244189.79%72.4475
Dividend per share 002.50%822.50%4102.50%41042.86%8042.86%400
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP